Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Skin Cancer Prevention

Irrational risk assessment by sunless tanning products?

    • Congress Reports
    • Dermatology and venereology
    • Prevention and health care
    • RX
    • Studies
  • 2 minute read

Sunless tanning products may contribute to riskier UV radiation exposure behaviors, according to a recent study from the Mannheim Public Health Institute.

This misperception may lead to riskier behavior by exposing individuals to prolonged exposure to tanning beds or the sun without sunscreen. The results of the present study emphasize the importance of target group-specific prevention and, in particular, the propagation of safe SBP use.

Predictor of riskier behavior?

A research group from the Mannheim Public Health Institute investigated whether SBP use is more common among users of tanning beds (misperception hypothesis) and whether SBP consumers have higher risk “awareness” regarding tanning bed use (healthy alternative hypothesis). A dataset was used from the second wave of the NCAM study (2016 National Cancer Aid Monitoring on Sunbed Use), which was based on a representative sample in Germany (n=3000; age 14-45; 48.6% female, 51.4% male). The interviews were conducted by telephone.  Differences between SBP users and non-users with respect to the above aspects were assessed using a chi-square test.

 

 

Risk “awareness” varies

During the last 12 months, 7.5% of the respondents used SBP (Fig. 1). Users of tanning beds showed a higher prevalence of SBP use than those who used tanning beds previously or never (16.1% vs. 9.6% vs. 5.8%; p<0.001; Fig. 2).

 

 

Although SBP users had a higher risk of skin cancer due to family history (e.g., family history of malignant melanoma: 12.2% vs. 7.1%; p=0.016), they were less aware of the risks of tanning bed use than non-users of SBPs (e.g., agreement with the item “Regular use of tanning beds causes skin cancer”: 75.7% vs. 84.2%; p=0.001).

Conclusion

The parallel use of SBP and tanning beds found in this representative study supports the misconception hypothesis. This can have serious health consequences because a “fake” complexion due to SBP can result in risky UV radiation exposure behaviors (concerning tanning beds and/or sunbathing). Neither the misconception hypothesis nor the healthy alternative hypothesis can be definitively confirmed or rejected based on the data of the present study. Further studies are needed to verify whether and how dangerous SBP use is.

Source: 46th ADF Annual Meeting, Munich (D), March 13-16, 2019.

 

Literature:

  1. Diehl K, et al.: Sunless tanning products: Healthy alternative or risky addition to tanning bed use? Mannheim Institue of Public Health, Social and Preventive Medicine, Medical Faculty Mannheim, Heidelberg University, Poster presentation (P084), 46th ADF Annual Meeting, Munich, 13-16 March 2019.
  2. Diehl K, et al: Profile of sunless tanning product users: results from a Nationwide Representative Survey. Photodermatology, Photoimmunology & Photomedicine 2019; 95 (1); 40-46.

 

DERMATOLOGIE PRAXIS 2019; 29(3): 30 (published 7.6.19, ahead of print).

Autoren
  • Mirjam Peter, M.Sc.
Publikation
  • DERMATOLOGIE PRAXIS
Related Topics
  • Prevention
  • Skin cancer
  • tanning products
  • UV
Previous Article
  • Phenotyping of severe influenza courses

Be critical of steroids

  • Congress Reports
  • General Internal Medicine
  • Infectiology
  • RX
View Post
Next Article
  • Cardiology

Anticoagulation in daily practice – where to be careful?

  • Cardiology
  • Education
  • General Internal Medicine
  • RX
View Post
You May Also Like
View Post
  • 13 min
  • Focus on prevention

Colorectal cancer screening – an update

    • CME continuing education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Oncology
    • Prevention and health care
    • RX
View Post
  • 11 min
  • Late-Breaking Science

Antithrombotics & rhythm

    • Cardiology
    • Congress Reports
    • RX
    • Studies
View Post
  • 3 min
  • Prostate cancer

Diagnosis without drama – ESMO 2025 under the banner of differentiated patient management

    • Congress Reports
    • Oncology
    • RX
    • Studies
    • Urology
View Post
  • 8 min
  • Pneumococcal conjugate vaccine (PCV)

Best possible serotype coverage in the respective age group

    • Education
    • General Internal Medicine
    • Infectiology
    • Pneumology
    • Prevention and health care
    • RX
    • Studies
View Post
  • 9 min
  • Psoriasis: intervening in the inflammatory cascade

Advantages of early biologic therapy and oral peptide as a beacon of hope

    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • Rheumatology
    • RX
    • Studies
View Post
  • 6 min
  • AI-supported imaging and new biomarkers

CHD diagnostics update

    • Cardiology
    • Education
    • RX
    • Studies
View Post
  • 4 min
  • Bipolar disorder, anxiety disorder, depression

Lurasidone as monotherapy for bipolar I depression with anxiety symptoms

    • Education
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 5 min
  • Arterial hypertension: ESC guideline 2024 in focus

New category “elevated blood pressure” – what are the therapeutic implications?

    • Cardiology
    • Congress Reports
    • General Internal Medicine
    • RX
Top Partner Content
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    Consideration of the tumor microenvironment opens up new treatment options
  • 2
    What screening tools are helpful?
  • 3
    Scleroderma – Current recommendations for diagnosis and therapy 2025
  • 4
    Advantages of topical pharmacotherapy – Update 2025
  • 5
    Ritual, party or new therapy? Psychedelics and more: clinically illuminated

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.